BRIGHT MINDS BIOSCIENCES INC.
For the period ended Mar 31, 2026. Filed May 20, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Mar 31, 2026 · Filed May 20, 2026
Use the contents to explore the available documents and sections.
DRUG$23.00+11.1%Stored close · as of Nov 6, 2026
Contents
SUBMITTED HEREWITH
| Exhibits | |
|---|---|
| 99.1 | Condensed Interim Consolidated Financial Statements for the six months ended March 31, 2026 and 2025 |
| 99.2 | Management's Discussion and Analysis for the Second Quarter Ended March 31, 2026 |
| 99.3 | Certification of Interim Filings - CEO |
| 99.4 | Certification of Interim Filings - CFO |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.